Investors

Symbol: IRME

Designs and develops devices utilizing spectrographic usability medical devices based on the combination of Infra-Red (IR) and Artificial Intelligence (AI) technologies. The company was founded in 2012 and is headquartered in Rosh Pina, Israel.

Press Release

IR-Med Letter to Shareholders

IR-Med to Become Fully Reporting SEC Company

IR-Med, Inc. Announces the Appointment of Dr. Rom Eliaz as Chief Executive Officer

IR-Med, Inc. Announces the Resignation of Limor Davidson Mund as CEO and Appointment of Chairman of the Board Oded Bashan as Interim Chief Executive Officer

IR-Med, Inc. Announces FINRA Approval of Name Change and Ticker Symbol Change to “IRME”

INTERNATIONAL DISPLAY ADVERTISING, INC. ANNOUNCES COMPLETION OF REVERSE MERGER AND CLOSING OF $2.2 MILLION PRIVATE PLACEMENT

Financial Statments

August 15, 2022
10-Q - Period Ending 06/30/22
May 16, 2022
10-Q - Period Ending 03/31/22
March 31, 2022
10-K - Period Ending 12/31/21
November 15, 2021
10-Q - Period Ending 09/30/21
August 29, 2021
Q2 2021 - Quarterly Report
March 31, 2021
Q1 2021 - Quarterly Report